ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 1107

$566K Total Retail Price of All Prescriptions

Rank: 320 out of 1107

514 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 514 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 514 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 9,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 600 395 S3 1 1
LISINOPRIL 595 464 2 2
LEVOTHYROXINE SODIUM 544 462 3 3
AMLODIPINE BESYLATE 399 370 4 6
PRAVASTATIN SODIUM 396 345 5 12
SIMVASTATIN 360 319 6 5
HYDROCHLOROTHIAZIDE 326 316 7 11
ZOLPIDEM TARTRATE 281 208 8 22
OMEPRAZOLE 238 187 9 4
CITALOPRAM HBR 217 120 10 17
ATENOLOL 214 171 11 19
METFORMIN HCL 208 128 12 8
GABAPENTIN 199 125 13 9
LOSARTAN POTASSIUM 190 161 14 29
FUROSEMIDE 170 132 15 7
TRAMADOL HCL 167 124 16 26
METOPROLOL TARTRATE 157 128 17 10
METFORMIN HCL ER 153 143 18 58
METOPROLOL SUCCINATE 151 122 19 16
TAMSULOSIN HCL 149 110 20 30
GLIPIZIDE 145 113 21 64
CLOPIDOGREL 135 118 22 28
DIOVAN 133 131 23 51
ATORVASTATIN CALCIUM 125 96 24 13
KLOR-CON M20 125 96 24 75
LOVASTATIN 114 108 26 55
TRAZODONE HCL 108 88 27 33
BENAZEPRIL HCL 108 86 27 86
CLONIDINE HCL 100 98 29 53
MELOXICAM 98 93 30 25
AMLODIPINE BESYLATE-BENAZEPRIL 97 97 31 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 66 32 24
SERTRALINE HCL 92 51 33 20
PLAVIX 87 74 34 39
WARFARIN SODIUM 80 80 35 15
VERAPAMIL ER 77 67 36 113
FLUTICASONE PROPIONATE 77 57 36 38
AZITHROMYCIN 77 60 36 35
CARVEDILOL 73 54 39 27
TRIAMTERENE-HCTZ 69 46 40 62
POTASSIUM CHLORIDE 66 62 41 14
DONEPEZIL HCL 65 65 42 32
PREDNISONE 64 45 43 40
PROPRANOLOL HCL 63 54 44 134
DIOVAN HCT 62 60 45 106
ALLOPURINOL 61 39 46 36
TIZANIDINE HCL 59 16 47 73
CRESTOR 59 45 47 23
SYNTHROID 57 53 49 70
RAMIPRIL 57 48 49 84
AMOXICILLIN 56 42 51 90
OXYBUTYNIN CHLORIDE 55 50 52 171
DICLOFENAC SODIUM 54 36 53 74
ISOSORBIDE MONONITRATE ER 54 51 53 34
MEGESTROL ACETATE 52 38 R 55 178
CIPROFLOXACIN HCL 51 44 56 59
BUPROPION XL 50 31 57 200
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.